Ondine Biomedical (OBI) Competitors C$15.00 -0.50 (-3.23%) As of 05:08 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesBuy This Stock OBI vs. BTG, ABC, GNS, ONT, ERGO, OXB, SLN, HZD, PRTC, and FARNShould you be buying Ondine Biomedical stock or one of its competitors? The main competitors of Ondine Biomedical include BTG (BTG), Abcam (ABC), Genus (GNS), Oxford Nanopore Technologies (ONT), Ergomed (ERGO), Oxford Biomedica (OXB), Silence Therapeutics (SLN), Horizon Discovery Group plc (HZD.L) (HZD), PureTech Health (PRTC), and Faron Pharmaceuticals Oy (FARN). These companies are all part of the "biotechnology" industry. Ondine Biomedical vs. Its Competitors BTG Abcam Genus Oxford Nanopore Technologies Ergomed Oxford Biomedica Silence Therapeutics Horizon Discovery Group plc (HZD.L) PureTech Health Faron Pharmaceuticals Oy Ondine Biomedical (LON:OBI) and BTG (LON:BTG) are both mid-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, dividends, risk, profitability, analyst recommendations, media sentiment, earnings and institutional ownership. Is OBI or BTG more profitable? BTG has a net margin of 0.00% compared to Ondine Biomedical's net margin of -873.84%. BTG's return on equity of 0.00% beat Ondine Biomedical's return on equity.Company Net Margins Return on Equity Return on Assets Ondine Biomedical-873.84% -684.01% -159.71% BTG N/A N/A N/A Which has preferable valuation and earnings, OBI or BTG? BTG has higher revenue and earnings than Ondine Biomedical. Ondine Biomedical is trading at a lower price-to-earnings ratio than BTG, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOndine BiomedicalC$2.05M3,788.92-C$424.66K-C$0.07-214.29BTG£914.10M0.00N/A£28.50N/A Do insiders & institutionals hold more shares of OBI or BTG? 23.0% of Ondine Biomedical shares are owned by institutional investors. 37.3% of Ondine Biomedical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Does the media refer more to OBI or BTG? In the previous week, BTG had 11 more articles in the media than Ondine Biomedical. MarketBeat recorded 13 mentions for BTG and 2 mentions for Ondine Biomedical. Ondine Biomedical's average media sentiment score of 0.70 beat BTG's score of 0.35 indicating that Ondine Biomedical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ondine Biomedical 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive BTG 2 Very Positive mention(s) 3 Positive mention(s) 6 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryBTG beats Ondine Biomedical on 7 of the 10 factors compared between the two stocks. Get Ondine Biomedical News Delivered to You Automatically Sign up to receive the latest news and ratings for OBI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OBI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OBI vs. The Competition Export to ExcelMetricOndine BiomedicalBiotechnology IndustryMedical SectorLON ExchangeMarket CapC$7.76BC$236.97MC$5.86BC$2.58BDividend YieldN/A3.78%5.68%5.30%P/E Ratio-214.2941.0874.525,410.66Price / Sales3,788.924,994.05536.7896,691.07Price / Cash1.9913.1937.5627.93Price / Book1,737.19103.7512.167.76Net Income-C$424.66K-C$90.99MC$3.28BC$5.89B7 Day Performance-1.64%3.36%0.98%6.49%1 Month Performance11.11%23.87%7.20%56.20%1 Year Performance127.27%550.36%63.06%148.15% Ondine Biomedical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OBIOndine BiomedicalN/AC$15.00-3.2%N/A+143.1%C$7.76BC$2.05M-214.29N/AGap DownBTGBTGN/AN/AN/AN/A£3.26B£914.10M29.474,690ABCAbcamN/AN/AN/AN/A£2.81B£350.40M20,433.331,650Gap UpHigh Trading VolumeGNSGenus0.9726 of 5 starsGBX 2,760+10.4%GBX 2,725-1.3%+39.5%£1.81B£671.60M-44,516.13480Gap UpHigh Trading VolumeONTOxford Nanopore Technologies2.54 of 5 starsGBX 163.90+0.2%GBX 246.67+50.5%+21.4%£1.58B£183.19M-1,024.381,281Analyst ForecastERGOErgomedN/AN/AN/AN/A£701.00M£152.09M4,641.386OXBOxford Biomedica1.4826 of 5 starsGBX 573-0.3%GBX 540.25-5.7%+79.4%£608.52M£128.80M-1,372.46891SLNSilence TherapeuticsN/AN/AN/AN/A£480.35M£11.35M-11.01100High Trading VolumeHZDHorizon Discovery Group plc (HZD.L)N/AN/AN/AN/A£302.98M£54.63M-33.55416PRTCPureTech Health1.7152 of 5 starsGBX 116.60+0.2%GBX 455+290.2%-21.6%£281.37M£6.17M555.24300News CoverageGap UpFARNFaron Pharmaceuticals OyN/AGBX 202.40-1.3%N/A-10.7%£236.72MN/A-697.9334News Coverage Related Companies and Tools Related Companies BTG Competitors Abcam Competitors Genus Competitors Oxford Nanopore Technologies Competitors Ergomed Competitors Oxford Biomedica Competitors Silence Therapeutics Competitors Horizon Discovery Group plc (HZD.L) Competitors PureTech Health Competitors Faron Pharmaceuticals Oy Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:OBI) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredDo NOT Day Trade (Do THIS instead)Forget day trading (especially in markets like these). Trade OVERNIGHT instead! I've uncovered a shockin...Monument Traders Alliance | SponsoredWall Street laughed at Trump’s “Smart Dollar.” Now they’re all in."THIS is the Biggest Economic Story of 2025" While most Americans are focused on tariffs and inflation, the...Stansberry Research | SponsoredTrump Devises the Death of the IRS ☠️Trump has just signed an executive order creating America's first-ever National Investment Fund — a game-chang...Angel Publishing | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ondine Biomedical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ondine Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
